LdAg-based prophylactic vaccine decreases <i>Leishmania</i> parasitic burden. by Doumet Georges Helou (7255823)

DHA combined with the glycolysis inhibitor decreases cell viability and induces apoptosis in NSCLC cells. by Yan-jun Mi (264759)

WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

“…Corresponding densitometry analysis is noted as protein fold expression compared to GAPDH for WT1, p<0.001(***), vFLIP(ns), LANA p<0.05(*), pAKT p<0.05(*), and BCL2 p <0.05(*) using two-sided, unpaired student t-tests. …”

Decreased cell growth of PGRN knock-out cell line as determined by the MTT assay. by Weifeng Zhang (134361)

Knockdown of CoREST1 decreased tumor cell-mediated macrophage migration and activation. by Sohini Mazumdar (707540)

mir-93 inhibits tumor growth and metastasis by decreasing CSCs in SUM159 cells. by Suling Liu (9555)

Transcription of feeding peptides and inflammation markers were regulated by treatment with palmitate in mHypoE-46 neurons. by Wenqing Ye (3015147)

Fig 5 - by Ke Lu (124270)

Subjects:

OA-stimulated VSMC proliferation and migration is associated with decreased expression of PGC-1α. by Yan Zhang (8098)

Nepmucin/CD300LG expression is decreased in tumors and tumor-draining lymph nodes. by Eiji Umemoto (1637)

Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

“…(A-B) GCase levels as assessed by the CBE/4-MU method are significantly decreased in the het <i>GBA1</i> D409V KI mice at 5 months of age in both brain (A) and liver (B). …”

Lipolytic treatment decreased cellular neutral lipids and increased extracellular fatty acids and glycerol. by Caroline Louis (332423)

“…Cellular neutral lipids (corresponding to µmol of fatty acids in cellular neutral lipids) were expressed per mg of total cell protein (A). A significant decrease of cellular lipid contents was noted throughout the lipolytic process for the conditions with PCB-28 (<i>p</i> = 0.005) and the cocktail of PCBs (<i>p</i> = 0.029). …”

Bacterial abundance in L2 larvae collected from larval flasks inoculated with decreasing quantities of glycerol stock (bacteria source). by Margaret V. Becker (21387776)

Correlations between SARS-CoV-2 specific T cells and FEV₁ and symptoms in PASC. by Katherine M. Littlefield (12647420)

Injection of pNaKtide diminishes PNx-induced decrease in miR-29b-3p expression. by Christopher A. Drummond (3845110)

Citrulline plus SO scavenging by PEG-SOD+PEG-CAT provides complete protection. by Irene Gramaglia (6439613)

FGF18 injections increase TIMP1 and decrease MMP13 and NOGGIN, suggesting healing of degeneration induction of anabolic effect. by Flavia Gomes Velasque Gama (21175112)

GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

“…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”

PKCε activation induces aggrecan gene expression, decreases ADAMTS5, and detection of ADAMTS-5-depended cleavage of ECM aggrecan through upregulation of hsa-miR-377 expression. by Emmanouella Tsirimonaki (490707)

“…<p>(<b>A</b>) RT-PCR detected the relative expression of ACAN, MKI67, ADAMTS5 after treatment of NP cells with 1 μM ψεRACK (or vehicle) for indicated times and revealed that time-dependent activation of PKCε significantly increased the mRNA expression for aggrecan, while in an opposing manner decreased ADAMTS5; mRNA levels of the proliferation marker Ki67 became barely detectable after 8 hours of PKCε activation. …”

Foxm1 deletion after tumor initiation decreases lung tumor expansion/progression. by I-Ching Wang (348231)